Safety, immunogenicity and field efficacy studies of a plasmodium falciparum malaria pre-erythrocytic stage vaccine.

Project Information

Grant agreement ID: BIO4972164

Project closed

Start date 1 September 1997

End date 28 February 2001

Funded under

• Specific research, technological development and demonstration programme in the field of biotechnology, 1994-1998

Total cost No data

EU contribution No data

Coordinated by

SMITHKLINE BEECHAM BIOLOGICALS S.A
Belgium

Fields of science

• medical and health sciences › health sciences › infectious diseases › malaria
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs › vaccines

Programme(s)

• FP4-BIOTECH 2 - Specific research, technological development and demonstration programme in the field of biotechnology, 1994-1998

Topic(s)

• 0502 - Transdisease vaccinology

Call for proposal

Data not available

Funding Scheme

CSC - Cost-sharing contracts

Coordinator

SMITHKLINE BEECHAM BIOLOGICALS S.A

• EU contribution: No data
• Address: 89,Rue de l'Institut 89 ; 1330 RIXENSART ; Belgium
• Total cost: No data

Participants (2)

London School of Hygiene and Tropical Medicine

United Kingdom

• EU contribution: No data
• Address: Keppel Street ; WC1E 7HT London
• Total cost: No data

The Chancellor, Masters and Scholars of the University of Oxford

United Kingdom

• EU contribution: No data
• Address: John Radcliffe Hospital Headington ; OX3 9DU Oxford
• Total cost: No data